About
VoxCell BioInnovation develops perfusable, vascularized human tissue models using 3D bioprinting to enable preclinical drug testing without animal models, focusing on drug distribution, target engagement, and toxicity assessment.
Explore VoxCell BioInnovation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.